Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 26/74 ]
NASDAQ | Common Stock
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network.
The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories.
It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release.
In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system.
Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.
The company was founded in 1999 and is based in Brentwood, Tennessee.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 30, 26 | -0.19 Increased by +50.73% | -0.18 Decreased by -4.88% |
| Mar 3, 26 | -0.17 Increased by +59.92% | -0.21 Increased by +19.96% |
| Nov 4, 25 | -0.18 Decreased by -800.00% | -0.24 Increased by +25.00% |
| Aug 12, 25 | -0.28 Increased by +3.45% | -0.27 Decreased by -3.70% |
| May 5, 25 | -0.38 Increased by +10.79% | -0.26 Decreased by -48.86% |
| Mar 10, 25 | -0.43 Increased by +67.40% | -0.31 Decreased by -39.39% |
| Nov 7, 24 | -0.02 Increased by +93.55% | -0.29 Increased by +93.10% |
| Aug 6, 24 | -0.29 Increased by +30.95% | -0.39 Increased by +25.64% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 47.80 M Increased by +16.47% | -9.43 M Increased by +21.28% | Decreased by -19.73% Increased by +32.41% |
| Dec 31, 25 | 45.45 M Decreased by -23.65% | -11.64 M Increased by +37.66% | Decreased by -25.62% Increased by +18.34% |
| Sep 30, 25 | 44.23 M Decreased by -21.94% | -6.94 M Decreased by -962.48% | Decreased by -15.70% Decreased by -1.20 K% |
| Jun 30, 25 | 45.45 M Increased by +14.47% | 105.18 M Increased by +234.87% | Increased by +231.40% Increased by +217.82% |
| Mar 31, 25 | 41.04 M Increased by +10.05% | -11.98 M Increased by +36.59% | Decreased by -29.19% Increased by +42.38% |
| Dec 31, 24 | 59.53 M Increased by +3.97% | -18.68 M Increased by +70.06% | Decreased by -31.37% Increased by +71.21% |
| Sep 30, 24 | 56.66 M Increased by +0.90% | 805.00 K Increased by +106.07% | Increased by +1.42% Increased by +106.01% |
| Jun 30, 24 | 39.71 M Decreased by -30.36% | -77.99 M Decreased by -324.89% | Decreased by -196.40% Decreased by -510.13% |